Literature DB >> 19665836

Wnt signaling can substitute for estrogen to induce division of ERalpha-positive cells in a mouse mammary tumor model.

Melissa Mastroianni1, Soyoung Kim, Young Chul Kim, Amanda Esch, Caroline Wagner, Caroline M Alexander.   

Abstract

The interaction of estrogen with the estrogen receptor (ER, principally ERalpha) induces growth of human breast tumor cells. In contrast, ERalpha-positive cells have been described as non-dividing cells in normal breast (though estrogen stimulation of ERalpha cells directs the division of neighboring cells). However, there is a small sub-population of cells in normal mammary tissue that are ERalpha-positive, that can divide, and therefore share this property with human breast tumor cells. In order to investigate their pattern of growth regulation, we measured the fraction of dividing ERalpha(+) cells during normal growth and compared that to glands stimulated by oncogenic Wnt effectors. First, we found there was no difference between the rate of division of ERalpha(+) cells and ERalpha(-) cells, whether the population was responding to estrogen or Wnt mitogens. The proportion of dividing ERalpha(+) mammary epithelial cells was increased (10x) in response to pregnancy, and similar increases were observed in response to ectopic Wnt signaling. We propose that Wnt signaling can substitute for estrogen to drive total population growth (that includes ERalpha(+) cells). Although the E-ERalpha-derived mitogenic response is situated in a minority of the luminal cells, and the Wnt-LRP5/6-derived mitogenic response is situated in a minority of basal cells, overall, the growth response of the mammary epithelial population is remarkably similar. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665836      PMCID: PMC2874254          DOI: 10.1016/j.canlet.2009.07.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

1.  Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

Authors:  B S Shoker; C Jarvis; R B Clarke; E Anderson; J Hewlett; M P Davies; D R Sibson; J P Sloane
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis.

Authors:  Charlotta Lindvall; Nicole C Evans; Cassandra R Zylstra; Yi Li; Caroline M Alexander; Bart O Williams
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

3.  Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice.

Authors:  Kenneth B R Ewan; Hellen A Oketch-Rabah; Shraddha A Ravani; G Shyamala; Harold L Moses; Mary Helen Barcellos-Hoff
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.

Authors:  W P Bocchinfuso; W P Hively; J F Couse; H E Varmus; K S Korach
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

5.  Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.

Authors:  Xiaomei Zhang; Katrina Podsypanina; Shixia Huang; Syed K Mohsin; Gary C Chamness; Sarah Hatsell; Pam Cowin; Rachel Schiff; Yi Li
Journal:  Oncogene       Date:  2005-06-16       Impact factor: 9.867

6.  Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland.

Authors:  Sonia Mallepell; Andrée Krust; Pierre Chambon; Cathrin Brisken
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-01       Impact factor: 11.205

7.  Oestrogen receptor expression in the normal and pre-cancerous breast.

Authors:  B S Shoker; C Jarvis; D R Sibson; C Walker; J P Sloane
Journal:  J Pathol       Date:  1999-07       Impact factor: 7.996

8.  Steroid hormone receptor status of mouse mammary stem cells.

Authors:  Marie-Liesse Asselin-Labat; Mark Shackleton; John Stingl; François Vaillant; Natasha C Forrest; Connie J Eaves; Jane E Visvader; Geoffrey J Lindeman
Journal:  J Natl Cancer Inst       Date:  2006-07-19       Impact factor: 13.506

9.  Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.

Authors:  Suh-Chin J Lin; Kuo-Fen Lee; Alexander Yu Nikitin; Susan G Hilsenbeck; Robert D Cardiff; Aihua Li; Keon-Wook Kang; Steven A Frank; Wen-Hwa Lee; Eva Y-H P Lee
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

10.  Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland.

Authors:  Katherine E Sleeman; Howard Kendrick; David Robertson; Clare M Isacke; Alan Ashworth; Matthew J Smalley
Journal:  J Cell Biol       Date:  2006-12-26       Impact factor: 10.539

View more
  14 in total

Review 1.  Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.

Authors:  Caroline M Alexander; Shruti Goel; Saja A Fakhraldeen; Soyoung Kim
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

Review 2.  Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.

Authors:  Gerard A Tarulli; Geraldine Laven-Law; Reshma Shakya; Wayne D Tilley; Theresa E Hickey
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-09-21       Impact factor: 2.673

3.  Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.

Authors:  Leander Blaas; Fabio Pucci; Hendrik A Messal; Agneta B Andersson; E Josue Ruiz; Marco Gerling; Iyadh Douagi; Bradley Spencer-Dene; Alexandra Musch; Richard Mitter; Leena Bhaw; Richard Stone; Dorothee Bornhorst; Abdul K Sesay; Jos Jonkers; Gordon Stamp; Ilaria Malanchi; Rune Toftgård; Axel Behrens
Journal:  Nat Cell Biol       Date:  2016-10-31       Impact factor: 28.824

Review 4.  Deciphering the divergent roles of progestogens in breast cancer.

Authors:  Jason S Carroll; Theresa E Hickey; Gerard A Tarulli; Michael Williams; Wayne D Tilley
Journal:  Nat Rev Cancer       Date:  2016-11-25       Impact factor: 60.716

5.  Lrp5 Has a Wnt-Independent Role in Glucose Uptake and Growth for Mammary Epithelial Cells.

Authors:  Emily N Chin; Joshua A Martin; Soyoung Kim; Saja A Fakhraldeen; Caroline M Alexander
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

Review 6.  Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.

Authors:  Lisa M Arendt; Charlotte Kuperwasser
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-19       Impact factor: 2.673

Review 7.  ERrrr…where are the progenitors? Hormone receptors and mammary cell heterogeneity.

Authors:  Giusy Tornillo; Matthew J Smalley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-21       Impact factor: 2.673

8.  A phenotypic mouse model of basaloid breast tumors.

Authors:  Soyoung Kim; Avtar Roopra; Caroline M Alexander
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

9.  Transcriptome analysis of the hormone-sensing cells in mammary epithelial reveals dynamic changes in early pregnancy.

Authors:  Duvini De Silva; Kamini Kunasegaran; Sujoy Ghosh; Alexandra M Pietersen
Journal:  BMC Dev Biol       Date:  2015-01-27       Impact factor: 1.978

10.  Genotoxic exposure during juvenile growth of mammary gland depletes stem cell activity and inhibits Wnt signaling.

Authors:  Kristine S Klos; Soyoung Kim; Caroline M Alexander
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.